Abstract: The invention relates to a method for coating surfaces with micro- and nanoparticles, the micro- and nanoparticles being chemically bonded to the surface, comprising the steps of pre-treatment of the surface with a plasma method, simultaneous or subsequent application of the micro- and nanoparticles to the surface, and subsequent fixation of the micro and nanoparticles on the surface using a plasma method, characterized in that the fixation of the micro- and nanoparticles takes place with the aid of anisothermal plasmas, the median electrical energy of which lies in the range of the bond dissociation energy of the micro- and nanoparticles, thus allowing the strength of the chemical bond between the surface and the micro- and nanoparticles to be variably set.

Abstract: The invention relates to adhesives for medical applications and methods of their preparation and use.

Abstract: The invention relates to a method for coating surfaces with micro- and nanoparticles, the micro- and nanoparticles being chemically bonded to the surface, comprising the steps of pre-treatment of the surface with a plasma method, simultaneous or subsequent application of the micro- and nanoparticles to the surface, and subsequent fixation of the micro and nanoparticles on the surface using a plasma method, characterized in that the fixation of the micro- and nanoparticles takes place with the aid of anisothermal plasmas, the median electrical energy of which lies in the range of the bond dissociation energy of the micro- and nanoparticles, thus allowing the strength of the chemical bond between the surface and the micro- and nanoparticles to be variably set.

Abstract: The invention relates to adhesives for medical applications and methods of their preparation and use.

Abstract: The invention relates to a kit comprising the following individual components: (a) polymers comprising at least one free amino group, (b) bridge molecules selected from the group consisting of monocyclic ortho-dihydroxyaromates, mono-cyclic para-dihydroxyaromates, bicyclic monohydrxyaromates, polycyclic monohydroxyaromates, bicyclic dihydroxyaromates, polycyclic dihydroxyaromates, bicyclic trihydroxyaromates, polycyclic trihydroxyaromates, and mixtures thereof, and (c) polyphenoloxidases, in particular, lignolytic polyphenoloxidases, whereby the individual components b) and c) are not in contact.

Abstract: The invention relates to novel antimicrobial agents that are based on ?-lactam derivatives and are produced by reacting previously known ?-lactam derivatives with polyphenol oxidase substrates under the influence of free radicals and by forming salts of any ?-lactam derivatives with polyhexamethylene biguanide hydrogen carbonate. Said novel compounds are suitable as an antibiotic.

Abstract: The invention relates to a kit comprising the following individual components: (a) polymers comprising at least one free amino group, (b) bridge molecules selected from the group consisting of monocyclic ortho-dihydroxyaromates, mono-cyclic para-dihydroxyaromates, bicyclic monohydrxyaromates, polycyclic monohydroxyaromates, bicyclic dihydroxyaromates, polycyclic dihydroxyaromates, bicyclic trihydroxyaromates, polycyclic trihydroxyaromates, and mixtures thereof, and (c) polyphenoloxidases, in particular, lignolytic polyphenoloxidases, whereby the individual components b) and c) are not in contact.

Abstract: A resorbable bone replacement material made of calcium phosphate particles of different phases which are embedded in an inventive-specific cross-linked collagen matrix. The goal is to form a non-brittle, bone replacement moulded body having a positive fit, i.e. having a shape which is anatomic and/or corresponds to the defect, which perfectly fills the bone defect and can be resorbed thereby. Said goal is achieved by producing the bone replacement material made of a mixture of calcium phosphate particles which is embedded in an inventive cross-linked collagen matrix. In particular, the collagen cross-linking is achieved by a Laccase-induced peptide cross-linking and suitable bridge molecules. Essentially substituted dihydroxyarmotes and/or substrates of the lignolytic polyphenoloxidases, such as Laccases, are suitable as bridge molecules.

Abstract: The invention relates to pharmaceutically or cosmetically active agents, which are obtained by converting biomasses consisting of lipid-containing marine organisms into microparticles and nanoparticles and which preferably have an average diameter of 10 nm 10 ?m. Possible fields of application of these agents include the field of medicine, the production of cosmetics or the production of foodstuffs and, in particular, the agents are used for the prophylaxis of nosocomial infections, accelerating cell growth and for inhibiting staphylococci.